Teva has launched a digitally-enabled inhaler in the UK, the first European market for the device, for use by patients with asthma and chronic obstructive pulmonary disorder (COPD). The GoResp ...
Studies show that up to 94 percent of patients use an inhaler incorrectly and therefore fail to get any benefit from the medication ... AARP is a nonprofit, nonpartisan organization that empowers ...
GSK has developed a new propellant technology for inhaler devices that drastically reduces their use of greenhouse gases, which perhaps surprisingly account for nearly half (49%) of the group’s ...
Also in today's edition: Supreme Court on cases of disputed religious places; will India have simultaneous elections soon; temple troubles in West Bengal; and more ...